Springfield, IL, United States of America

Thomas Brozoski

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas Brozoski: Innovator in Tinnitus Treatment

Introduction

Thomas Brozoski is a notable inventor based in Springfield, IL (US). He has made significant contributions to the field of medicine, particularly in the treatment of chronic tinnitus. His innovative approach has the potential to improve the quality of life for many individuals suffering from this condition.

Latest Patents

Brozoski holds a patent for "Neuronal nicotinic acetylcholine receptor partial agonists as therapeutics for chronic tinnitus." This patent outlines a method for treating subjects with symptoms of tinnitus and includes pharmaceutical compositions that comprise one or more of the following: sazetidine, a pharmaceutically acceptable salt of sazetidine, varenicline, a pharmaceutically acceptable salt of varenicline, or any combination thereof. This invention represents a promising advancement in tinnitus therapy.

Career Highlights

Thomas Brozoski is affiliated with Southern Illinois University, where he continues to engage in research and development in the field of auditory health. His work is characterized by a commitment to finding effective treatments for chronic conditions, showcasing his dedication to improving patient outcomes.

Collaborations

Brozoski has collaborated with esteemed colleagues, including Donald Caspary and Brandon Cox. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

In summary, Thomas Brozoski is a pioneering inventor whose work in tinnitus treatment has the potential to make a significant impact in the medical field. His innovative patent and collaborations reflect his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…